The latest thoracic oncology news
A variant of the CTLA-4 gene associated with autoimmune disease was found to be more…
Non-small cell lung cancer (NSCLC) is a devastating disease and the leading cause of American…
Scientists at the Cancer Research UK Cambridge Institute used a personalised blood test for patients,…
More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker…
A consensus reached by a lung clinical community within the International Cancer Benchmarking Partnership (ICBP),…
Nonsmokers with the two most common types of driver-gene mutated lung cancer have higher levels…
A Yale Cancer Center research team (USA) has identified novel oncogenic gene fusions in lung…
Australians with lung conditions will be able to access the world’s first and only dedicated…
Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) approved nivolumab 360…
An unexpected discovery at UVA Cancer Center, USA, has allowed scientists to halt the development of small-cell…